July 18, 2019
StemRIM Resides in “Saito Bio-Incubator” in Ibaraki, Osaka With an IPO looming early next month, Kensuke Tomita, chairman and CEO of Osaka-based StemRIM, revealed his company’s plan to submit what would be the world’s first tissue regeneration-inducing medicine in Japan...read more